| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | budesonide (Cortiment®) |
| Formulation | 9 mg prolonged-release tablet |
| Reference number | 1512 |
| Indication | Induction of remission in patients with mild to moderate active ulcerative colitis where 5-ASA treatment is not sufficient |
| Company | Ferring Pharmaceuticals (UK) |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 29/06/2015 |